Results 171 to 180 of about 274,722 (228)
Some of the next articles are maybe not open access.
Epicutaneous immunotherapy: A review of safety and efficacy
Pediatric Allergy and ImmunologyEpcutaneous immunotherapy (EPIT) is a novel, non‐oral route of allergen immunotherapy, utilizing the skin and its robust density of epidermal Langerhans cells (LC) for antigen presentation.
A. Anagnostou, M. Greenhawt
semanticscholar +3 more sources
Sustained antigens delivery using composite microneedles for effective epicutaneous immunotherapy
Drug Delivery and Translational Research, 2023Allergen-specific immunotherapy (SIT) is a desirable way of therapy for various allergic diseases such as food allergy (FA). However, frequent visits for more than 3 years and potential adverse effects often hinder patient compliance. Recently, many researchers started focusing on microneedles (MNs) as a new method for SIT.
Erkang Zhang +4 more
semanticscholar +3 more sources
Epicutaneous Immunotherapy for Peanut Allergy
AAP Grand Rounds, 2023semanticscholar +2 more sources
Engineered Iontophoresis Patch for Epicutaneous Allergen‐specific Immunotherapy
Advanced Functional MaterialsEpidermal immunotherapy represents an emerging treatment method for allergic diseases. Nevertheless, an unformidable obstacle for epidermal drug delivery is the dense stratum corneum of the skin.
Zhiting Cao +7 more
semanticscholar +2 more sources
Challenging the norm: Epicutaneous immunotherapy for canine atopic dermatitis
Allergy, 2023Marta Pinto +10 more
semanticscholar +3 more sources
Epicutaneous immunotherapy desensitizes toddlers with peanut allergy
The Journal of PediatricsM. Ben-Shoshan, E. Abrams
semanticscholar +2 more sources
Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy.
New England Journal of Medicine, 2023BACKGROUND No approved treatment for peanut allergy exists for children younger than 4 years of age, and the efficacy and safety of epicutaneous immunotherapy with a peanut patch in toddlers with peanut allergy are unknown.
M. Greenhawt +65 more
semanticscholar +1 more source
Journal of Allergy and Clinical Immunology: In Practice, 2023
CLINICAL IMPLICATIONS BOX Severity of eczema at patch application site during epicutaneous immunotherapy could be an independent predictor of subsequent response to oral immunotherapy.
Camille Braun +6 more
semanticscholar +1 more source
CLINICAL IMPLICATIONS BOX Severity of eczema at patch application site during epicutaneous immunotherapy could be an independent predictor of subsequent response to oral immunotherapy.
Camille Braun +6 more
semanticscholar +1 more source
Annals of Allergy, Asthma & Immunology, 2023
The treatment ...
M. Greenhawt +12 more
semanticscholar +1 more source
The treatment ...
M. Greenhawt +12 more
semanticscholar +1 more source

